AI Clinical Scribe Competitive Landscape 2026: Positioning Prontua in the Brazilian Market
AI Clinical Scribe Competitive Landscape 2026: Positioning Prontua in the Brazilian Market
Product: Prontua | Date: 2026-04-08 | Requested by: Aline Sentone (Design)
Executive Summary
The AI clinical documentation market is experiencing rapid growth globally, with established players processing millions of consultations weekly. Six competitors were analyzed across three tiers: global leaders (Freed, Heidi Health), Brazilian incumbents (Voa Health, CoDoutor), and niche entrants (PatientNotes, MedLens AI).
The Brazilian market has a clear frontrunner — Voa Health — with 60K+ physicians, $14.4M in seed funding (Prosus Ventures), and voice-first clinical documentation. However, no competitor combines dedicated recording hardware + AI clinical assistant + usage-based pricing. This triple differentiation is Prontua’s positioning opportunity.
Key finding: The market is validated. Brazilian physicians are adopting AI scribes. The question is not “will doctors use this?” but “how does Prontua win against funded incumbents?“
1. Competitor Profiles
1.1 Freed (US Market Leader)
| Attribute | Detail |
|---|---|
| Website | getfreed.ai |
| HQ | United States |
| Scale | 26,000+ clinicians, 1,200+ clinics |
| Core product | AI medical scribe: voice-to-text, SOAP notes, EHR push, ICD-10/CPT coding |
| Pricing | $39/mo (40 notes), $79/mo (unlimited), $104/mo (EHR push + coding) |
| Compliance | HIPAA + SOC 2 Type II |
Strengths:
- Low entry price ($39) with free trial removes adoption friction
- Broad specialty coverage (20+ specialties)
- Direct EHR push integration at Premier tier — strong workflow lock-in
- ICD-10/CPT auto-coding (CPT in beta) adds revenue cycle value
Weaknesses:
- Note cap on Starter tier (40/mo) penalizes high-volume practices early
- US-only positioning — no Brazilian market presence
- CPT coding still in beta — incomplete for revenue cycle
- Enterprise pricing is opaque
What to learn: Tiered pricing with clear feature gates. Free trial as top-of-funnel. Specialty-specific templates increase stickiness.
What to avoid: Note caps on entry tier create frustration. Beta features advertised as selling points erode trust.
1.2 Heidi Health (Global, AU-Founded)
| Attribute | Detail |
|---|---|
| Website | heidihealth.com |
| HQ | Melbourne, Australia |
| Scale | 2M+ consultations/week, 116 countries, 110+ languages |
| Core product | Ambient AI scribe + “Heidi Evidence” clinical decision support |
| Pricing | Free (limited), $150/user/mo (Clinician), Custom (Enterprise) |
| Compliance | HIPAA, GDPR, SOC 2, ISO 27001 |
Strengths:
- Massive scale (2M consults/week) proves ambient scribe model works
- Free tier drives viral adoption — doctors try before committing
- “Heidi Evidence” (launched Feb 2026) adds clinical decision support with NHS/BMJ backing
- 110+ languages = near-universal accessibility
- Passive ambient listening = near-zero workflow disruption
Weaknesses:
- EHR integration is copy-paste, not native API push
- $150/mo is expensive for solo practitioners in emerging markets
- Complex cases still require manual editing
What to learn: Free tier as growth engine. Clinical decision support as a differentiation layer beyond transcription. Passive ambient UX.
What to avoid: Copy-paste EHR integration feels incomplete. High price point excludes emerging market solo practitioners.
1.3 Voa Health (Brazil — Primary Threat)
| Attribute | Detail |
|---|---|
| Website | voa.health |
| HQ | Belo Horizonte, Brazil |
| Scale | 60,000+ physicians, 1M+ consultations processed |
| Core product | Voice → structured clinical docs, prescriptions, patient history summary |
| Pricing | Free trial, subscription (not public), B2B/clinic tier available |
| Funding | $14.4M seed (Prosus Ventures + Credipago) |
| Compliance | LGPD compliant |
Strengths:
- Dominant Brazilian scale: 60K physicians is a real moat
- Prosus backing = enterprise credibility + distribution channels
- Voice-first UX optimized for medical Portuguese
- Founded 2023, already at significant scale — fast execution
Weaknesses:
- No pricing transparency = friction in self-serve conversion
- Generalist positioning risks losing to specialty-specific tools
- No dedicated hardware — relies on ambient device microphones
- No visible AI assistant/copilot features (transcription only)
What to learn: Brazilian market is ready and hungry for AI clinical tools. Voice-first is the right UX paradigm. Scale is achievable quickly.
What to avoid: Opaque pricing. Trying to out-distribute a Prosus-backed competitor head-on.
Strategic implication: Voa is the gorilla. Prontua cannot out-spend or out-distribute them. Must differentiate on hardware quality, AI assistant depth, and pricing model.
1.4 CoDoutor (Brazil — Direct Competitor, Beta)
| Attribute | Detail |
|---|---|
| Website | codoutor.com.br |
| HQ | Brazil |
| Scale | Unknown — beta stage, no visible customer count |
| Core product | Audio transcription → SOAP notes + prescriptions + TUSS/CBHPM billing codes + WhatsApp patient follow-ups |
| Pricing | Free during beta, paid tiers TBD |
| Compliance | LGPD compliant (Google Cloud) |
Strengths:
- WhatsApp patient follow-up automation — brilliant for Brazilian market norms
- TUSS/CBHPM billing code automation — direct revenue impact for doctors
- “Style Learning” adapts to each physician’s writing patterns
- Chrome extension for EHR integration
Weaknesses:
- Beta-only with no public pricing — confidence risk
- No native mobile app (web only)
- Unknown traction — no case studies or visible customer base
- Limited to Brazil
What to learn: WhatsApp integration is a strong differentiator in Brazil. Billing code automation (TUSS/CBHPM) has direct financial value for doctors. Style personalization increases note acceptance rate.
What to avoid: Launching in perpetual beta without clear pricing signals.
Strategic implication: CoDoutor is the closest feature-competitor but lacks traction and mobile presence. Prontua’s hardware + mobile-native advantage is significant.
1.5 PatientNotes (AU/US — Budget Option)
| Attribute | Detail |
|---|---|
| Website | patientnotes.app |
| HQ | Australia |
| Scale | 7 App Store ratings — very early |
| Core product | Ambient scribe, SOAP notes, medical letters, referral generation |
| Pricing | $19/mo (Essential), $49/mo (Professional), 14-day free trial |
| Compliance | HIPAA + GDPR, BAA available |
Strengths:
- Aggressive entry pricing ($19/mo) — lowest in the market
- Clean mobile-first UX, low friction onboarding
- Australian PMS integrations (Cliniko, Nookal, Genie)
Weaknesses:
- Minimal traction (7 ratings)
- No billing code automation
- No specialty-specific optimization
- 30-day transcript deletion may conflict with retention requirements
What to learn: Price can be a wedge. Mobile-first UX with simple onboarding reduces adoption friction.
What to avoid: Going too broad without depth. Transcript deletion policies that conflict with medical regulations.
1.6 MedLens AI (Brazil/iOS — Early Stage)
| Attribute | Detail |
|---|---|
| Website | App Store |
| HQ | Unknown |
| Scale | No ratings/reviews — pre-traction |
| Core product | Ambient scribe + voice dictation + 50+ clinical risk calculators |
| Pricing | R$59.90/week, R$199.90/mo, R$1,299.90/mo (unlimited), R$1,999.90/yr |
| Compliance | Claims enterprise security, unverified by Apple |
Strengths:
- 50+ clinical risk score calculators (Wells, CHA2DS2-VASc, etc.) add utility beyond transcription
- Multi-platform (iPhone, iPad, Mac M1)
Weaknesses:
- Zero traction — no reviews
- Aggressive pricing without proven value (R$1,300/mo unlimited tier)
- English-only interface in a Portuguese-speaking market
- Privacy data collection flagged as unverified by Apple
What to learn: Clinical calculators add sticky utility beyond transcription — worth considering as a feature.
What to avoid: Launching with high pricing and no social proof. English-only in Brazil.
2. Feature Comparison Matrix
| Capability | Prontua | Freed | Heidi | Voa | CoDoutor | PatientNotes | MedLens |
|---|---|---|---|---|---|---|---|
| Voice recording | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| SOAP generation | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| AI clinical assistant | Yes | No | Yes | No | No | No | Partial |
| Dedicated hardware | Yes | No | No | No | No | No | No |
| WhatsApp automation | No | No | No | No | Yes | No | No |
| EHR integration | No | API push | Copy-paste | Unknown | Chrome ext | AU PMS | No |
| Billing codes | No | ICD-10/CPT | No | No | TUSS/CBHPM | No | No |
| Clinical calculators | No | No | No | No | No | No | Yes (50+) |
| Brazilian market | Yes | No | Partial | Yes | Yes | No | Yes |
| Portuguese-native | Yes | No | Yes (110+ lang) | Yes | Yes | No | No |
| Free tier/trial | No | Trial | Free tier | Trial | Beta (free) | Trial | No |
| Native mobile app | Yes | Web | Yes | Unknown | No | Yes | Yes |
| Usage-based pricing | Yes | No | No | No | No | No | No |
3. Pricing Landscape
| Player | Model | Entry Price | Full Price | Notes |
|---|---|---|---|---|
| Prontua | Per-use | R$3.90/SOAP | R$3.90/SOAP | Zero commitment, scales with usage |
| Freed | Subscription | $39/mo (40 notes) | $104/mo | Note caps on entry |
| Heidi | Freemium | $0 (limited) | $150/mo | Expensive for solo BR doctors |
| Voa | Subscription | Free trial | Unknown | Opaque pricing |
| CoDoutor | TBD | Free (beta) | TBD | No pricing yet |
| PatientNotes | Subscription | $19/mo | $49/mo | Cheapest subscription |
| MedLens | Subscription | R$60/week | R$1,300/mo | Aggressive, unproven |
Prontua’s pricing advantage: Usage-based pricing (R$3.90/SOAP) is unique in the market. A doctor doing 10 consultations/day, 22 days/month = 220 SOAPs = R$858/mo. Competitive with subscriptions but with zero upfront commitment. For lighter users (5/day), it’s R$429/mo — cheaper than most.
4. Competitive Positioning
Where Prontua sits
HIGH FEATURE DEPTH
|
Heidi | Freed
(global, | (US, EHR+coding,
free tier, | enterprise)
evidence) |
|
LOW PRICE ──────────────┼────────────── HIGH PRICE
|
PatientNotes | MedLens
($19/mo, | (R$1,300/mo,
basic) | no traction)
|
LOW FEATURE DEPTH
Brazilian quadrant:
- Voa: mid-price, mid-features, HIGH SCALE
- CoDoutor: free (beta), mid-features, NO SCALE
- Prontua: usage-based, high features + hardware, EARLY STAGEProntua’s Unique Position
No competitor occupies the intersection of:
- Hardware + software (dedicated recording device for superior audio)
- AI clinical copilot (not just transcription — dosages, differentials, summaries)
- Usage-based pricing (pay per SOAP, no subscription commitment)
- Brazilian-native (Portuguese, LGPD, local medical protocols)
5. Strategic Recommendations
Differentiate (do these, nobody else does)
- Hardware quality moat — Superior audio capture = superior transcription = superior notes. This is a physical moat that software-only competitors cannot replicate quickly.
- AI assistant as retention hook — The clinical copilot (dosages, differentials, protocol lookups) keeps doctors coming back even when not recording. Make it the daily clinical companion, not just a scribe.
- Usage-based pricing — Zero commitment, scales naturally. Market it as “R$3.90 por prontuario” — a fraction of what a doctor earns per consultation.
Adopt (learn from competitors)
- WhatsApp follow-ups (from CoDoutor) — Patient communication in Brazil runs through WhatsApp. Automated follow-up reminders would be high-value.
- TUSS/CBHPM billing codes (from CoDoutor) — Direct financial value for doctors. Every SOAP that auto-generates billing codes saves administrative time.
- Clinical calculators (from MedLens) — 50+ risk score calculators add utility beyond transcription and increase daily usage.
- Free tier or trial (from Heidi/Freed) — Critical for adoption. Consider a “first 10 SOAPs free” onboarding model.
Avoid (anti-patterns observed)
- Opaque pricing (Voa, CoDoutor) — Doctors want to know what they’ll pay before signing up
- Note caps on entry tiers (Freed) — Creates frustration at the moment of highest engagement
- English-only in Brazil (MedLens) — Table stakes: must be Portuguese-native
- Perpetual beta without pricing (CoDoutor) — Signals lack of confidence
- High subscription before proven value (MedLens at R$1,300/mo) — Doctors won’t pay premium without social proof
6. Threat Assessment
| Competitor | Threat Level | Reason |
|---|---|---|
| Voa Health | High | 60K BR physicians, $14.4M funding, same market |
| CoDoutor | Medium | Feature overlap, but beta with no traction |
| Heidi Health | Medium | Global scale, but not Brazil-focused |
| Freed | Low | US-only, no BR market interest visible |
| MedLens AI | Low | No traction, English-only |
| PatientNotes | Low | AU-focused, no BR presence |
7. Recommended Positioning Statement
Prontua is the first AI clinical assistant built for Brazilian doctors that combines a dedicated recording device with intelligent SOAP note generation and a clinical copilot — all at R$3.90 per consultation, with zero monthly commitment.
Tagline options:
- “Prontuarios clinicos com IA” (current — clear, functional)
- “Seu copiloto clinico” (Your clinical copilot — differentiates from pure scribes)
- “Grave. Receba. Atenda.” (Record. Receive. Care. — action-oriented)
8. Next Steps
- Deep Research dispatch — Full structured analysis with TAM/SAM/SOM sizing, regulatory landscape, and GTM playbook (pending Paperclip CPO issue creation)
- Voa Health deep-dive — Dedicated analysis of the primary threat: their pricing, churn signals, user complaints, feature gaps
- Hardware differentiation validation — User interviews with doctors about audio quality pain points with phone-based recording
- Pricing model validation — A/B test usage-based (R$3.90/SOAP) vs. subscription (R$99/mo unlimited) with early adopters
Report status: Preliminary. Based on web research by 6 parallel agents. Full structured memo pending CPO/Deep Research dispatch via Paperclip.